Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 2047-2056

  Jullien, Nicolas ^a,b   Maudinet, Adrien ^a,b   Leloutre, Benjamin ^a,b   Ringe, Jochen ^c   Häupl, Thomas ^c   Marie, Pierre J ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ErbB3; MESENCHYMAL CELLS; OSTEOBLAST; Wnt SIGNALING

Indexed keywords

ALKALINE PHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; NEU DIFFERENTIATION FACTOR; SMALL INTERFERING RNA; WNT3A PROTEIN;

ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; ENZYME ACTIVITY; MESENCHYMAL STEM CELL; MESENCHYME CELL; MICROARRAY ANALYSIS; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANDROSTADIENES; ANIMALS; APOPTOSIS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C3H; NEUREGULIN-1; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, ERBB-3; RNA INTERFERENCE; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

MURINAE;

EID: 84859577298     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24076     Document Type: Article

References (56)

1. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S,. 2005. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280: 41342-41351.
2. Bianco P, Riminucci M, Gronthos S, Robey PG,. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19: 180-192.
3. Birchmeier C,. 2009. ErbB receptors and the development of the nervous system. Exp Cell Res 315: 611-618.
4. Blume-Jensen P, Hunter T,. 2001. Oncogenic kinase signalling. Nature 411: 355-365.
5. Bodine PV, Komm BS,. 2006. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 7: 33-39.
6. Britsch S,. 2007. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 190: 1-65.
7. Canalis E, Raisz LG,. 1979. Effect of epidermal growth factor on bone formation in vitro. Endocrinology 104: 862-869.
8. Caplan AI,. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
9. Carraway KL III, Sweeney C,. 2001. Localization and modulation of ErbB receptor tyrosine kinases. Curr Opin Cell Biol 13: 125-130.
10. Chan SY, Wong RW,. 2000. Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275: 38693-38698.
11. Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, Patterson C, Neckers L, Fry DW, Yarden Y,. 2002. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: Implications for cancer therapy. EMBO J 21: 2407-2417.
12. Citri A, Skaria KB, Yarden Y,. 2003. The deaf and the dumb: The biology of ErbB-2 and ErbB-3. Exp Cell Res 284: 54-65.
13. Clines GA, Mohammad KS, Bao Y, Stephens OW, Suva LJ, Shaughnessy JD, Jr., Fox JW, Chirgwin JM, Guise TA,. 2007. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Mol Endocrinol 21: 486-498.
14. Clines GA, Mohammad KS, Grunda JM, Clines KL, Niewolna M, McKenna CR, McKibbin CR, Yanagisawa M, Suva LJ, Chirgwin JM, Guise TA,. 2011. Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor. J Bone Miner Res. 26: 2523-2536.
15. Day TF, Guo X, Garrett-Beal L, Yang Y,. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739-750.
16. Denny WA,. 2002. Irreversible inhibitors of the erbB family of protein tyrosine kinases. Pharmacol Ther 93: 253-261.
17. Falls DL,. 2003. Neuregulins: Functions, forms, and signaling strategies. Exp Cell Res 284: 14-30.
18. Fisher MC, Clinton GM, Maihle NJ, Dealy CN,. 2007. Requirement for ErbB2/ErbB signaling in developing cartilage and bone. Dev Growth Differ 49: 503-513.
19. Fromigué O, Hamidouche Z, Marie PJ,. 2008. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 283: 30549-30556.
20. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB,. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280: 33132-33140.
21. Gordon MD, Nusse R,. 2006. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429-22433.
22. Hamidouche Z, Haà E, Vaudin P, Charbord P, SchÃle R, Marie PJ, Fromigué O,. 2008. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J 22: 3813-3822.
23. Hamidouche Z, Fromigué O, Ringe J, Haüpl T, Vaudin P, Pages JC, Srouji S, Livne E, Marie PJ,. 2009. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci USA 106: 18587-18591.
24. Häupl T, Yahyawi M, Lubke C, Ringe J, Rohrlach T, Burmester GR, Sittinger M, Kaps C,. 2007. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen 12: 328-340.
25. Haà E, Faucheu C, Suc-Royer I, Touitou R, Stiot V, Vayssiere B, Baron R, Roman-Roman S, Rawadi G,. 2005. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J Biol Chem 280: 13616-13623.
26. Haà E, Laplantine E, Geoffroy V, Frain M, Kohler T, Muller R, Marie PJ,. 2009. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation. Mol Cell Biol 29: 953-964.
27. Hickinson DM, Klinowska T, Speake G, Vincent J, Trigwell C, Anderton J, Beck S, Marshall G, Davenport S, Callis R, Mills E, Grosios K, Smith P, Barlaam B, Wilkinson RW, Ogilvie D,. 2010. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: A unique agent for simultaneous ERBB receptor blockade in cancer. Clin Cancer Res 16: 1159-1169.
28. Ishizawar RC, Miyake T, Parsons SJ,. 2007. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 26: 3503-3510.
29. Johnson ML, Harnish K, Nusse R, Van Hul W,. 2004. LRP5 and Wnt signaling: A union made for bone. J Bone Miner Res 19: 1749-1757.
30. Kaabeche K, Lemonnier J, Le Mée S, Caverzasio J, Marie PJ,. 2004. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem 279: 36259-36267.
31. Kassem M, Abdallah BM,. 2008. Human bone-marrow-derived mesenchymal stem cells: Biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res 331: 157-163.
32. Katoh Y, Katoh M,. 2006. Canonical WNT signaling pathway and human AREG. Int J Mol Med 17: 1163-1166.
33. Kimelman N, Pelled G, Gazit Z, Gazit D,. 2006. Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med 1: 549-561.
34. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M,. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308: 1472-1477.
35. Krause DS, Van Etten RA,. 2005. Tyrosine kinases as targets for cancer therapy. N Engl J Med 353: 172-187.
36. Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, Pasqualini R, Arap W, Navone NM, Tu SM, Hu M, Yu-Lee LY, Logothetis CJ,. 2008. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene 27: 5195-5203.
37. Marie PJ, Fromigué O,. 2006. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1: 539-548.
38. Marie PJ, Hott M, Perheentupa J,. 1990. Effects of epidermal growth factor on bone formation and resorption in vivo. Am J Physiol 258: E275-E281.
39. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A,. 2000. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151: 311-320.
40. Niger C, Geneau G, Fiorini C, Defamie N, Pointis G, Mesnil M, Cronier L,. 2008. Endothelin-1 inhibits human osteoblastic cell differentiation: Influence of connexin-43 expression level. J Cell Biochem 103: 110-122.
41. Nusse R,. 2008. Wnt signaling and stem cell control. Cell Res 18: 523-527.
42. Olayioye MA, Badache A, Daly JM, Hynes NE,. 2001. An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway. Exp Cell Res 267: 81-87.
43. Orosco A, Fromigué O, Bazille C, Entz-Werle N, Levillain P, Marie PJ, Modrowski D,. 2007. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Cancer Res 67: 3708-3715.
44. Pentassuglia L, Sawyer DB,. 2009. The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 315: 627-637.
45. Phinney DG, Prockop DJ,. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-Current views. Stem Cells 25: 2896-2902.
46. Rodda SJ, McMahon AP,. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133: 3231-3244.
47. Samaga R, Saez-Rodriguez J, Alexopoulos LG, Sorger PK, Klamt S,. 2009. The logic of EGFR/ErbB signaling: Theoretical properties and analysis of high-throughput data. PLoS Comput Biol 5: e1000438.
48. Schneider MR, Sibilia M, Erben RG,. 2009. The EGFR network in bone biology and pathology. Trends Endocrinol Metab 20: 517-524.
49. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC,. 2006. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26: 2955-2964.
50. Suzuki A, Shinoda J, Watanabe-Tomita Y, Ozaki N, Oiso Y, Kozawa O,. 1997. ETA receptor mediates the signaling of endothelin-1 in osteoblast-like cells. Bone 21: 143-146.
51. Sweeney C, Carraway KL III., 2000. Ligand discrimination by ErbB receptors: Differential signaling through differential phosphorylation site usage. Oncogene 19: 5568-5573.
52. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A,. 2006. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24: 686-695.
53. von Schroeder HP, Veillette CJ, Payandeh J, Qureshi A, Heersche JN,. 2003. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 33: 673-684.
54. Wiley HS,. 2003. Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res 284: 78-88.
55. Xu Y, Li X, Zhou M,. 2009. Neuregulin-1/ErbB signaling: A druggable target for treating heart failure. Curr Opin Pharmacol 9: 214-219.
56. Zhang X, Tamasi J, Lu X, Zhu J, Chen H, Tian X, Lee TC, Threadgill DW, Kream BE, Kang Y, Partridge NC, Qin L,. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. J Bone Miner Res 26: 1022-1034.